Key result
Hemodialysis patients had significantly lower TAPSE (1.61 vs 2.09, P<0.001) and higher systolic pulmonary artery pressure (37.4 vs 19.0, P<0.001) compared to healthy controls.
Why the study?
Volume load assessment is challenging in chronic renal failure, and studies on echocardiographic evaluation of right heart functions are limited.
Do echocardiographic parameters of right heart function differ between hemodialysis patients and healthy controls?
Population
49 patients receiving hemodialysis and 46 matched healthy controls
Comparison
Hemodialysis patients vs age- and gender-matched healthy controls
Design
Case-control study
Authors
Loading...
May support right heart echo for volume assessment in hemodialysis; hypothesis-generating, requires prospective validation before adoption.
Case-Control (n=95)
Do echocardiographic parameters of right heart function differ between hemodialysis patients and healthy controls?
Absolute Event Rate: 1.61% vs 2.09%
p-value: p=<0.001
Echocardiographic parameters such as TAPSE and SPAP are significantly altered in hemodialysis patients and may serve as useful adjuncts for evaluating hypervolemia.
Ardahanlı et al. (2019) conducted a case-control in End-stage renal failure (n=95). Hemodialysis therapy vs. Healthy individuals was evaluated on Tricuspid annular plane systolic excursion (TAPSE) (p=<0.001). Hemodialysis patients had significantly lower TAPSE (1.61 vs 2.09, P<0.001) and higher systolic pulmonary artery pressure (37.4 vs 19.0, P<0.001) compared to healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: